MA31993B1 - Nouvel usage medical des sels de 3-(2,2,2-trimethylhydrazinium) propionate - Google Patents
Nouvel usage medical des sels de 3-(2,2,2-trimethylhydrazinium) propionateInfo
- Publication number
- MA31993B1 MA31993B1 MA32978A MA32978A MA31993B1 MA 31993 B1 MA31993 B1 MA 31993B1 MA 32978 A MA32978 A MA 32978A MA 32978 A MA32978 A MA 32978A MA 31993 B1 MA31993 B1 MA 31993B1
- Authority
- MA
- Morocco
- Prior art keywords
- propionate
- salts
- medical use
- trimetylhydrazinium
- new medical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La présente invention concerne un nouvel usage médical des sels de 3-(2,2,2-triméthylhydrazinium) propionate pour la fabrication d'un médicament destiné à la prévention et au traitement de l'athérosclérose.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07122273 | 2007-12-04 | ||
EP07122272 | 2007-12-04 | ||
PCT/EP2008/066711 WO2009071585A1 (fr) | 2007-12-04 | 2008-12-03 | Nouvel usage médical des sels de 3-(2,2,2-triméthylhydrazinium) propionate |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31993B1 true MA31993B1 (fr) | 2011-01-03 |
Family
ID=40481525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32978A MA31993B1 (fr) | 2007-12-04 | 2010-07-01 | Nouvel usage medical des sels de 3-(2,2,2-trimethylhydrazinium) propionate |
Country Status (32)
Country | Link |
---|---|
US (1) | US20100234459A1 (fr) |
EP (1) | EP2222293B1 (fr) |
JP (1) | JP2011505408A (fr) |
KR (1) | KR20100084688A (fr) |
CN (1) | CN101951898B (fr) |
AR (1) | AR069521A1 (fr) |
AT (1) | ATE518536T1 (fr) |
AU (1) | AU2008333262A1 (fr) |
BR (1) | BRPI0819057A2 (fr) |
CA (1) | CA2706354C (fr) |
CL (1) | CL2008003551A1 (fr) |
CO (1) | CO6280477A2 (fr) |
CY (1) | CY1112336T1 (fr) |
DK (1) | DK2222293T3 (fr) |
DO (1) | DOP2010000163A (fr) |
EA (1) | EA019424B1 (fr) |
GE (1) | GEP20125673B (fr) |
HR (1) | HRP20110744T1 (fr) |
IL (1) | IL205961A0 (fr) |
MA (1) | MA31993B1 (fr) |
MX (1) | MX2010006255A (fr) |
MY (1) | MY150508A (fr) |
PA (1) | PA8805901A1 (fr) |
PE (1) | PE20091037A1 (fr) |
PL (1) | PL2222293T3 (fr) |
PT (1) | PT2222293E (fr) |
RS (1) | RS51992B (fr) |
SI (1) | SI2222293T1 (fr) |
TN (1) | TN2010000250A1 (fr) |
TW (1) | TW200930356A (fr) |
WO (1) | WO2009071585A1 (fr) |
ZA (1) | ZA201003641B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2425835A1 (fr) * | 2010-08-18 | 2012-03-07 | Grindeks, a joint stock company | Nouvelle utilisation médicale de dihydrate propionate 3-(2,2,2-trimethylhydrazinium) et dérivés de flavonoïdes naturels |
TWI487524B (zh) * | 2010-12-03 | 2015-06-11 | Tetra Sia | 菸鹼酸和米曲肼之新穎治療組合 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2535150C (fr) * | 2003-08-04 | 2010-04-13 | Joint Stock Company "Grindeks" | Sels de meldonium stables et non hygroscopiques, methode de preparation desdits sels et compositions pharmaceutiques a base desdits sels |
-
2008
- 2008-11-26 TW TW097145676A patent/TW200930356A/zh unknown
- 2008-11-27 PE PE2008001984A patent/PE20091037A1/es not_active Application Discontinuation
- 2008-11-28 PA PA20088805901A patent/PA8805901A1/es unknown
- 2008-11-28 CL CL2008003551A patent/CL2008003551A1/es unknown
- 2008-12-02 AR ARP080105237A patent/AR069521A1/es unknown
- 2008-12-03 JP JP2010536438A patent/JP2011505408A/ja not_active Ceased
- 2008-12-03 AT AT08857026T patent/ATE518536T1/de active
- 2008-12-03 EP EP08857026A patent/EP2222293B1/fr active Active
- 2008-12-03 AU AU2008333262A patent/AU2008333262A1/en not_active Abandoned
- 2008-12-03 CA CA2706354A patent/CA2706354C/fr not_active Expired - Fee Related
- 2008-12-03 EA EA201000738A patent/EA019424B1/ru not_active IP Right Cessation
- 2008-12-03 RS RS20110470A patent/RS51992B/en unknown
- 2008-12-03 PL PL08857026T patent/PL2222293T3/pl unknown
- 2008-12-03 MY MYPI20102603 patent/MY150508A/en unknown
- 2008-12-03 KR KR1020107012218A patent/KR20100084688A/ko active Search and Examination
- 2008-12-03 GE GEAP200811832A patent/GEP20125673B/en unknown
- 2008-12-03 US US12/734,779 patent/US20100234459A1/en not_active Abandoned
- 2008-12-03 CN CN2008801194045A patent/CN101951898B/zh not_active Expired - Fee Related
- 2008-12-03 PT PT08857026T patent/PT2222293E/pt unknown
- 2008-12-03 SI SI200830410T patent/SI2222293T1/sl unknown
- 2008-12-03 WO PCT/EP2008/066711 patent/WO2009071585A1/fr active Application Filing
- 2008-12-03 MX MX2010006255A patent/MX2010006255A/es not_active Application Discontinuation
- 2008-12-03 DK DK08857026.2T patent/DK2222293T3/da active
- 2008-12-03 BR BRPI0819057 patent/BRPI0819057A2/pt not_active IP Right Cessation
-
2010
- 2010-05-21 ZA ZA2010/03641A patent/ZA201003641B/en unknown
- 2010-05-25 IL IL205961A patent/IL205961A0/en unknown
- 2010-06-01 TN TN2010000250A patent/TN2010000250A1/fr unknown
- 2010-06-02 DO DO2010000163A patent/DOP2010000163A/es unknown
- 2010-06-03 CO CO10067244A patent/CO6280477A2/es not_active Application Discontinuation
- 2010-07-01 MA MA32978A patent/MA31993B1/fr unknown
-
2011
- 2011-10-13 HR HR20110744T patent/HRP20110744T1/hr unknown
- 2011-10-25 CY CY20111101004T patent/CY1112336T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN08313A1 (fr) | Des formes pharmaceutiques resistantes a la modification | |
CY1118630T1 (el) | Στερεες μορφες 3-(6-(1-(2,2-διφθοροβενζο[d][1,3]διοξολ-5-υλο)-κυκλοπροπανοκαρβοξαμ1δο)-3-μεθυλοπυριδιν-3-υλο)-βενζοϊκου οξεος | |
NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
CY1118523T1 (el) | Πεπτιδικες ενωσεις για την θεραπεια του ανθεκτικου status epilepticus | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
MA33593B1 (fr) | Composés hétérocycliques et leurs utilisations | |
DK2148670T3 (da) | Titrering af tapentadol | |
UA112055C2 (uk) | Солі 4-[2-[[5-метил-1-(2-нафталініл)-1h-піразол-3-іл]оксі]етил]морфоліну | |
TW200833370A (en) | Pharmaceutical composition containing low substituted hydroxypropylcellulose | |
DE502004003249D1 (en) | (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum | |
ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
FR2890865B1 (fr) | Enceinte de desinfection d'instruments medicaux. | |
CY1110658T1 (el) | Χρηση του καρραγηνου για τη θεραπεια μολυνσεων απο ρινοϊο | |
FR2902010B1 (fr) | Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique | |
DK1853241T3 (da) | Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyclohexandion ved behandling af Parkinson's sygdom | |
DK1670903T3 (da) | Behandling af neurodegenerative sygdomme | |
DK1778837T3 (da) | Behandling af neurodegenerative sygdomme ved anvendelse af SCD4-inhibitorer | |
MA31993B1 (fr) | Nouvel usage medical des sels de 3-(2,2,2-trimethylhydrazinium) propionate | |
FR2905600B1 (fr) | Traitement des vertiges par l'acetyl-l-leucine. | |
MA31100B1 (fr) | Nouvelle utilisation therapeutique pour le traitement des leucemies | |
FR2884716B1 (fr) | Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires | |
MA31385B1 (fr) | Utilisation d'inhibiteurs de hdac pour le traitement de la destruction osseuse | |
MA29400B1 (fr) | Agent pour la prevention ou le traitement d'un trouble nocturne du comportement associe a la demence | |
FR2918281B1 (fr) | Medicament pour le traitement de la maladie de parkinson. | |
MA30925B1 (fr) | Le dmae en tant qu'agent unique pour le traitement de deficit cognitif leger |